Erratum: RAID: A valid tool to quantify the impact of rheumatoid arthritis. But what impact will it have on the core set for trials? (Annals of the Rheumatic Diseases (2011) 70 (884-885) DOI:10.1136/ard.2010.145375);RAID: A valid tool to quantify the impact of rheumatoid arthritis. But what impact will it have on the core set for trials?

Annals of the Rheumatic Diseases

Volumn 70, Issue 6, 2011, Pages 884-885

  Boers, Maarten ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL (TOPIC); COPING BEHAVIOR; COST CONTROL; DISEASE EXACERBATION; EDITORIAL; FATIGUE; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RELIABILITY; RHEUMATOID ARTHRITIS; RHEUMATOID ARTHRITIS IMPACT OF DISEASE SCORE; SCORING SYSTEM; SHORT FORM 36; SLEEP QUALITY; VALIDATION PROCESS; VALIDITY; WELLBEING;

EID: 79955864036     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.145375corr1     Document Type: Erratum

References (10)

1. Sanderson T, Kirwan J. Patient-reported outcomes for arthritis: time to focus on personal life impact measures? Arthritis Rheum 2009;61:1-3.
2. Boers M, Tugwell P, Felson DT, et al. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl 1994;41:86-9. (Pubitemid 24285550) (Pubitemid 24285550)
3. Kirwan J, Heiberg T, Hewlett S, et al. Outcomes from the Patient Perspective Workshop at OMERACT 6. J Rheumatol 2003;30:868-72. (Pubitemid 36402790) (Pubitemid 36402790)
4. Sanderson TC, Hewlett SE, Flurey C, et al. The impact triad (severity, importance, selfmanagement) as a method of enhancing measurement of personal life impact of rheumatic diseases. J Rheumatol 2011;38:191-4.
5. Tugwell P, Bombardier C, Buchanan WW, et al. The MACTAR Patient Preference Disability Questionnaire-an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol 1987;14:446-51. (Pubitemid 17121196) (Pubitemid 17121196)
6. Gossec L, Paternotte S, Aanerud GJ, et al. Finalisation and validation of the Rheumatoid Arthritis Impact of Disease (RAID) score, a patient-derived composite measure of impact of rheumatoid arthritis. A EULAR initiative. Ann Rheum Dis 2011;70:935-942.
7. Heiberg T, Austrad C, Kvien TK, et al. Performance of the RAID etc. Ann Rheum Dis 2011;70:1080-2.
8. Gossec L, Dougados M, Rincheval N, et al. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis 2009;68:1680-5.
9. Boers M, Brooks P, Strand CV, et al. The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998;25:198-9.
10. Kirwan JR, Minnock P, Adebajo A, et al. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol 2007;34:1174-7. (Pubitemid 46774870) (Pubitemid 46774870)